OKYO Pharma Limited (OKYO) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of OKYO Pharma Limited and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OKYO
OKYO Pharma Limited
$1.49HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
PDSB
PDS Biotechnology Corporation
$1.07HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
Total return — OKYO vs PDSB
growth of $100 · dividends reinvested · last 4yOKYO -59.4% (-20.2%/yr)PDSB -76.7% (-30.5%/yr)OKYO compounded faster over this window
OKYO PDSB
OKYO vs PDSB: by the numbers
- •PDSB is the larger company ($60M vs $57M market cap).
Metrics side by side
Valuation
| Metric | OKYO | PDSB |
|---|---|---|
| P/B ratio | 4.62 | N/A |
Profitability
| Metric | OKYO | PDSB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -72.55% | N/A |
| ROIC | -68.91% | -3699.99% |
Growth (annualized)
| Metric | OKYO | PDSB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -39.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.